ES2617989T3 - Agente para mejorar o mantener la QOL - Google Patents

Agente para mejorar o mantener la QOL Download PDF

Info

Publication number
ES2617989T3
ES2617989T3 ES12762904.6T ES12762904T ES2617989T3 ES 2617989 T3 ES2617989 T3 ES 2617989T3 ES 12762904 T ES12762904 T ES 12762904T ES 2617989 T3 ES2617989 T3 ES 2617989T3
Authority
ES
Spain
Prior art keywords
agent
qol
maintains
improves
lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12762904.6T
Other languages
English (en)
Spanish (es)
Inventor
Mina TSUBOUCHI
Takao Saito
Masamichi Toba
Noriyuki Kouda
Shoji Shinkai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2617989T3 publication Critical patent/ES2617989T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
ES12762904.6T 2011-03-31 2012-03-28 Agente para mejorar o mantener la QOL Active ES2617989T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011080814 2011-03-31
JP2011080814 2011-03-31
PCT/JP2012/058145 WO2012133533A1 (ja) 2011-03-31 2012-03-28 Qol改善又は持続剤

Publications (1)

Publication Number Publication Date
ES2617989T3 true ES2617989T3 (es) 2017-06-20

Family

ID=46931242

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12762904.6T Active ES2617989T3 (es) 2011-03-31 2012-03-28 Agente para mejorar o mantener la QOL

Country Status (12)

Country Link
US (2) US9623054B2 (enExample)
EP (1) EP2692349B1 (enExample)
JP (2) JP6061842B2 (enExample)
KR (1) KR101878525B1 (enExample)
CN (1) CN103458905A (enExample)
AU (1) AU2012233590B2 (enExample)
CA (1) CA2831554C (enExample)
ES (1) ES2617989T3 (enExample)
PH (1) PH12013501951A1 (enExample)
SG (3) SG10201602487SA (enExample)
TW (1) TWI642363B (enExample)
WO (1) WO2012133533A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017183595A1 (ja) * 2016-04-20 2017-10-26 株式会社 明治 疲労感の改善用の発酵乳
TWI583388B (zh) * 2016-08-24 2017-05-21 國立體育大學 胚芽乳酸桿菌用於製備改善運動表現及降低肌肉疲勞之益生菌組合物之用途
AU2020289102B2 (en) * 2019-06-03 2025-07-03 Asahi Group Holdings, Ltd. Walking ability improver
JP7593740B2 (ja) * 2020-03-02 2024-12-03 株式会社明治 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物
JP7703165B2 (ja) * 2020-07-27 2025-07-07 独立行政法人国立病院機構 Qol改善剤
TW202442251A (zh) * 2023-04-12 2024-11-01 葡萄王生技股份有限公司 抗疲勞乳酸菌組成物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
DE602004030922D1 (de) * 2003-08-21 2011-02-17 Otsuka Pharma Co Ltd Milchsäurebakterien mit mucosa-immunpotenzierungseffekt
CN101128122B (zh) * 2005-02-23 2011-02-09 大塚制药株式会社 基于茶的发酵饮料和茶饮料
US8182849B2 (en) 2005-02-23 2012-05-22 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
JP5467785B2 (ja) * 2009-03-25 2014-04-09 大塚製薬株式会社 抗鳥インフルエンザウイルス抗体の産生促進剤

Also Published As

Publication number Publication date
AU2012233590A1 (en) 2013-10-10
SG193508A1 (en) 2013-10-30
US20170216379A1 (en) 2017-08-03
SG10201912606QA (en) 2020-02-27
AU2012233590B2 (en) 2017-06-08
CN103458905A (zh) 2013-12-18
KR101878525B1 (ko) 2018-07-13
JPWO2012133533A1 (ja) 2014-07-28
SG10201602487SA (en) 2016-05-30
EP2692349A4 (en) 2014-11-05
EP2692349A1 (en) 2014-02-05
US10369177B2 (en) 2019-08-06
CA2831554A1 (en) 2012-10-04
EP2692349B1 (en) 2016-12-28
PH12013501951A1 (en) 2019-07-03
JP6061842B2 (ja) 2017-01-18
CA2831554C (en) 2021-08-03
TWI642363B (zh) 2018-12-01
JP6261688B2 (ja) 2018-01-17
TW201244647A (en) 2012-11-16
JP2017019841A (ja) 2017-01-26
US20140017217A1 (en) 2014-01-16
AU2012233590A2 (en) 2014-05-08
KR20140026433A (ko) 2014-03-05
US9623054B2 (en) 2017-04-18
WO2012133533A1 (ja) 2012-10-04

Similar Documents

Publication Publication Date Title
KR101095712B1 (ko) 점막 면역 부활 작용을 갖는 유산균
ES2617989T3 (es) Agente para mejorar o mantener la QOL
US20110038837A1 (en) Composition for improving intestinal microflora
CN111212575A (zh) 肌肉增量用组合物
ES2925635T3 (es) Bioconversión de oleuropeína
JP7041508B2 (ja) 概日リズム改善用組成物
JP5324283B2 (ja) 感染防御剤
KR100751865B1 (ko) 면역 부활 조성물
US8778332B2 (en) Agent for reducing risk of developing cancer
US20210352925A1 (en) Fermented formula with non digestible oligosaccharides for sleep improvement
JP2007527724A (ja) 有益な腸内微生物叢を促進するための果実および果汁のプレバイオティクス用途
US20130224252A1 (en) Intestine immunomodulator
EP3533453B1 (en) An agent comprising a lactic acid bacterium for use in reducing the risk of developing an eye disease or equilibrium dysfunction
JP7703165B2 (ja) Qol改善剤
JP2009254236A (ja) 新規乳酸菌並びに新規乳酸菌を利用した飲食品及び免疫賦活剤
JP2024008239A (ja) 末梢血の単球数増強用組成物
JP2022023806A (ja) 制御性t細胞調節剤およびその用途
HK1189816B (en) Agent for improving or maintaining qol
HK1189816A (en) Agent for improving or maintaining qol
KR20070030961A (ko) 항알레르기용 조성물